Edward Silverman | Jul 25, 1993 | 4 min read
The average annual base salary paid to executives at United States biotechnology companies--both privately and publicly owned--rose between 4.7 percent and 7.4 percent between 1991 and 1992, according to a recently released survey by executive search firm J. Robert Scott and accounting and consulting firm Coopers & Lybrand's National High Tech Group, both of Boston. Top biotechnology officials say the findings portend the future health and expansion of the industry, which, they say, should m